How Big is the 3D Printed Drug Market | Trends & Forecast 2025

Q: What is the current size and forecast of the 3D printed drug market?

The 3D printed drug market was valued at USD 174 million in 2024 and is projected to reach USD 652 million by 2031 at a CAGR of 20.7%.

Q: Which segments are witnessing the most growth?

Personalized dosage forms for chronic diseases, pediatric care, and rare disease treatment are seeing rapid adoption.

Q: What are the key drivers of demand?

Patient-specific medicine, regulatory support, and advancements in print-based pharmaceutical production.

Q: What challenges does the 3D printed drug market face?

High R&D costs, regulatory uncertainty in some countries, and limited commercial-scale production infrastructure.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA4491

Publication Date: Jun 2025

How big is the 3D Printed Drug Market?

According to 6Wresearch internal database and industry insights, the Global 3D Printed Drug Market was valued at approximately USD 174 million in 2024 and is projected to reach USD 652 million by 2031, growing at a CAGR of 20.7% during the forecast period.

This growth is fueled by advancements in personalized medicine, increasing regulatory support, and demand for patient-specific dosage forms in chronic and rare diseases.

Key Growth Drivers of the 3D Printed Drug Market

Rising demand for personalized drug delivery and targeted therapies
Growing incidence of chronic and age-related diseases requiring precision dosing
Regulatory support for innovative drug manufacturing methods
Improved drug solubility and release control through 3D printing techniques
Adoption by hospitals and research centers for rapid drug prototyping

3D Printed Drug Market Trends

The 3D printed drug market is observing the use of fused deposition modeling (FDM) and inkjet printing in customizable tablets. The first approved 3D drug by FDA was Spritam, which has led to more approvals. On-demand drug printing is being experimented with at hospitals and compounding pharmacies. A segment of pediatric and geriatric patients is an important target to pay attention to flexible dose design and easy to swallow formats.

Emerging Developments in the 3D Printed Drug Market

Emerging developments include multi-drug layered tablets, 3D-printed polypills, and bio responsive drugs with controlled release. Companies are collaborating with pharma research institutions to create personalized therapies for oncology and neurology. Bioprinting of tissues with embedded drugs for regenerative medicine is under exploration. AI integration is also enhancing formulation accuracy and print optimization.